Colonoscopy Before Age 50 May Cut Colorectal Cancer Risk in Women
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age
Women’s Health
FDA Extends Review Period for Relugolix Combo Therapy for Endometriosis Pain
The FDA extended the action date to review additional information regarding bone mineral density.
Bevacizumab Biosimilar Alymsys Gets FDA Approval
The approval was based on data demonstrating that the biosimilar product and the reference product were highly similar, and that there were no clinically meaningful differences between the agents.
Expert Roundtable: Updates in Postpartum Depression Treatment
While antidepressants and psychotherapy have helped many women with postpartum depression (PPD), established pharmacologic approaches for MDD do not target the proposed mechanisms of PPD, and studies have shown that a substantial number of patients with PPD do not achieve remission with antidepressants. We interviewed 3 experts on the subject.
HPV Vaccination May Be Cutting Cervical Cancer Rates
Might be too soon to tell impact on oropharyngeal and anal cancers
More Than Half of US Abortions Now Done With Pills
FDA approved mifepristone in 2000, and use of the abortion pills has been rising since then
Solosec Approval Expanded to Adolescents With Bacterial Vaginosis, Trichomoniasis
The overall safety findings of Solosec in pediatric patients were consistent with those observed in adult patients.
Study Shows Ibrexafungerp Prevents Recurrent Vulvovaginal Candidiasis
The phase 3 CANDLE study compared the efficacy and safety of ibrexafungerp to placebo in 260 female patients 12 years of age and older with rVVC.
Cemiplimab Application for Advanced Cervical Cancer Withdrawn
The decision was made to withdraw the application after the Companies and the FDA were not able to align on certain postmarketing studies.
COVID-19 Vaccination Does Not Impact Fertility, Study Says
Participants were asked to report on COVID-19 vaccination status and prior SARS-CoV-2 infection, in addition to income and education levels, lifestyle, and reproductive and medical histories.
